STUDIES OF CLONAL CELL-LINES DEVELOPED FROM PRIMARY BREAST CANCERS INDICATE THAT THE ABILITY TO UNDERGO MORPHOGENESIS INVITRO IS LOST EARLY IN MALIGNANCY

被引:33
作者
SHEARER, M [1 ]
BARTKOVA, J [1 ]
BARTEK, J [1 ]
BERDICHEVSKY, F [1 ]
BARNES, D [1 ]
MILLIS, R [1 ]
TAYLORPAPADIMITRIOU, J [1 ]
机构
[1] IMPERIAL CANC RES FUND,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND
关键词
D O I
10.1002/ijc.2910510417
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In an attempt to obtain cell lines from the different components found in primary breast cancers, we used a low-calcium medium to culture epithelial cells of mixed phenotype and a recombinant T antigen containing retrovirus to immortalize cells found in these cultures. In each case, the histology of the sample used for culture was examined in detail and the best growth was obtained from samples associated with a substantial in situ or benign component and from lobular rather than ductal carcinomas. Clonal cell lines were developed from each of 4 tumours: I infiltrating ductal (tumour number 2), 2 infiltrating lobular (tumours 3 and 5) and I mucoid (tumour 6). To try to identify the phenotype and origin of the cell lines, immunohistochemical markers, histological analysis of tissue sections and behavioural markers were used. All the cell lines expressed mainly luminal epithelial cell markers, but the basal epithelial keratin, keratin 14, was also expressed homogeneously or heterogeneously. Growth in agar was seen with some but not all cell lines derived from only I tumour (tumour 5) and tumour development in nude mice was observed (with low efficiency) with cell lines from only I tumour (tumour 6). The data suggest that the cell lines obtained from the infiltrating ductal carcinoma (tumour 2) developed from cells cultured from the associated benign component, while the cell lines from tumours 3, 5 and 6 may each have developed from a cell in an early stage of malignancy. When tested for their ability to undergo morphogenesis on extracellular matrix components, cell lines from tumour 2 made well-developed ductal-alveolar-like structures, while those from the other tumours did not.
引用
收藏
页码:602 / 612
页数:11
相关论文
共 33 条
  • [1] ADAMS TE, 1983, IMMUNOLOGY, V50, P613
  • [2] DISTINCTIVE TRAITS OF NORMAL AND TUMOR-DERIVED HUMAN MAMMARY EPITHELIAL-CELLS EXPRESSED IN A MEDIUM THAT SUPPORTS LONG-TERM GROWTH OF BOTH CELL-TYPES
    BAND, V
    SAGER, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) : 1249 - 1253
  • [3] EFFICIENT IMMORTALIZATION OF LUMINAL EPITHELIAL-CELLS FROM HUMAN MAMMARY-GLAND BY INTRODUCTION OF SIMIAN VIRUS-40 LARGE TUMOR-ANTIGEN WITH A RECOMBINANT RETROVIRUS
    BARTEK, J
    BARTKOVA, J
    KYPRIANOU, N
    LALANI, EN
    STASKOVA, Z
    SHEARER, M
    CHANG, S
    TAYLORPAPADIMITRIOU, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) : 3520 - 3524
  • [4] EXPRESSION OF MONOCLONAL ANTIBODY-DEFINED EPITOPES OF KERATIN-19 IN HUMAN-TUMORS AND CULTURED-CELLS
    BARTEK, J
    BARTKOVA, J
    SCHNEIDER, J
    TAYLORPAPADIMITRIOU, J
    KOVARIK, J
    REJTHAR, A
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (12): : 1441 - 1452
  • [5] BARTEK J, 1990, ONCOGENE, V5, P893
  • [6] BARTEK J, 1985, J CELL SCI, V75, P17
  • [7] PATTERNS OF EXPRESSION OF KERATIN-19 AS DETECTED WITH MONOCLONAL-ANTIBODIES IN HUMAN-BREAST TISSUES AND TUMORS
    BARTEK, J
    TAYLORPAPADIMITRIOU, J
    MILLER, N
    MILLIS, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (03) : 299 - 306
  • [8] A SERIES OF 14 NEW MONOCLONAL-ANTIBODIES TO KERATINS - CHARACTERIZATION AND VALUE IN DIAGNOSTIC HISTOPATHOLOGY
    BARTEK, J
    VOJTESEK, B
    STASKOVA, Z
    BARTKOVA, J
    KEREKES, Z
    REJTHAR, A
    KOVARIK, J
    [J]. JOURNAL OF PATHOLOGY, 1991, 164 (03) : 215 - 224
  • [9] MORPHOLOGICAL-DIFFERENTIATION OF HYBRIDS OF HUMAN MAMMARY EPITHELIAL-CELL LINES IS DOMINANT AND CORRELATES WITH THE PATTERN OF EXPRESSION OF INTERMEDIATE FILAMENTS
    BERDICHEVSKY, F
    TAYLORPAPADIMITRIOU, J
    [J]. EXPERIMENTAL CELL RESEARCH, 1991, 194 (02) : 267 - 274
  • [10] BRODSKY FM, 1982, J IMMUNOL, V128, P129